gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · NRCTechnologyR&D — Physical & Biological Sciences

NRC Health Common Stock (NRC)

$25.48−5.87%
Close Nov 5, 2026 · split-adjusted
Oct 30, 2026$23.83▲ 79.85% in range
Nov 3, 2025Low $12.03 · High $23.83Oct 30, 2026
What changed · written from our data
As of Nov 5, 2026

NRC Health closed at $25.48 on Nov 5, down 5.87%, 5.9% below its 52-week closing high. Volume of 256.2K shares was 2.60× its 20-day average (well above normal).

Split-adjusted performance: +26.2% over one month, +36.0% over six months, +84.9% over one year.

In the quarter ended Sep 30, 2026, revenue was $38.40M, up 11.0% from a year earlier, with a net margin of 12.3%.

Short interest was 725.6K shares at the Oct 15 settlement, up 5.8% from the prior report (7.2% of float, 8.1 days to cover).

Market cap$540.7M21.2M shares
Revenue · quarter$38.4M+11.0% YoY
Diluted EPS$0.21+16.7% YoY
P/E · TTM88.2×P/S 3.8×
Net margin12.3%Gross 60.0%
Dividend yield2.51%$0.16 last paid
52-week range12.03 – 27.07−5.9% from high
Volume256.2K2.60× 20-day avg
Volatility · 60d51.3%Annualised
Short % of float7.2%8.1 days to cover
Net cash-$99.3MCash $3.6M
Next earnings—Not scheduled
Split-adjusted performance
1W +8.5%1M +26.2%3M +25.3%6M +36.0%YTD +35.7%1Y +84.9%3Y −39.7%5Y −41.0%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within R&D — Physical & Biological Sciences

Percentile among 11 companies (100 = best)

6-month momentum40
Revenue growth60
Net margin90
Value (low P/E)—
Size40

Industry medians: 6-month return +48.1%, revenue growth +8.5%, net margin −122.0%, P/E 47.0×.

Short interest

Details →
Shares short725.6K+5.8% vs prior
Days to cover8.1Settled Oct 15
% of float7.2%
Short vol. 10d41.5%of daily volume

Closest peers by size in R&D — Physical & Biological Sciences

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
NRCNRC Health$25.48−5.87%+36.0%+11.0%12.3%88.2$540.7M
OABIOmniAb$4.83−6.76%+228.6%+78.3%−393.9%—$704.5MCompare
ABSIAbsci$9.39−10.40%+63.3%−46.4%−10443.4%—$1.61BCompare
MXCTMaxCyte$1.31−5.76%+50.3%−14.5%−122.0%—$135.2MCompare
IBACIB Acquisition$10.81−0.46%−0.2%———$54.1MCompare
ONMDOneMedNet$4.17−8.15%−57.3%+88.4%−743.8%—$24.3MCompare
CRLCharles River Laboratories International$313.02−4.07%+72.3%−2.7%−0.1%—$15.00BCompare
MEDPMedpace Holdings$634.98−3.32%+48.1%+8.5%19.2%34.3$17.76BCompare
INCYIncyte Genomics$118.01−3.94%+20.7%+14.0%−50.4%59.6$24.05BCompare

News about NRC Health

All news →

No recent articles focused on NRC Health.

Quick answers

What does NRC Health do?
NRC Health operates as a humanized healthcare and support organization. Its platform includes Listen, Understand, and Improve.
What is NRC's market cap?
$540.72M, based on the Nov 5 close of $25.48.
What is NRC's P/E ratio?
88.2× trailing-twelve-month earnings of $6.13M.
Does NRC Health pay a dividend?
Yes. The latest regular dividend was $0.16 per share (ex-date Sep 25), an annualised yield of 2.51%.
How much of NRC is sold short?
725.6K shares, 7.2% of float, as of Oct 15, 2026.
What sector is NRC in?
Technology, in the R&D — Physical & Biological Sciences industry.

About NRC Health

NRC Health operates as a humanized healthcare and support organization. Its platform includes Listen, Understand, and Improve. The group provides solutions for Patient, Consumer, Employee, and Market experiences. The group's commitment to Human Understanding helps healthcare systems get to know the patients, families, consumers, employees, and communities it on a human level.

HQ: Lincoln, NE357 employeesListed Oct 10, 1997nrchealth.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology